Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News ZimVie Inc ZIMV

ZimVie Inc. is a global life sciences company in the dental market. The Company develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. The Company works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental... see more

Recent & Breaking News (NDAQ:ZIMV)

ZimVie Announces Closing of Sale of Spine Business

GlobeNewswire April 1, 2024

ZimVie to Participate in the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire March 27, 2024

ZimVie Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire February 28, 2024

ZimVie to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

GlobeNewswire February 21, 2024

ZimVie Announces Launch of Next-Generation TSX® Implant in Japan

GlobeNewswire February 7, 2024

ZimVie Announces Definitive Agreement to Sell Spine Business to H.I.G. Capital for $375 Million

GlobeNewswire December 18, 2023

ZimVie Announces Compatibility Between its Vital(TM) Spinal Fixation System and Brainlab Spine & Trauma Navigation

GlobeNewswire December 12, 2023

ZimVie Reports Third Quarter 2023 Financial Results and Provides Update to Annual Guidance

GlobeNewswire November 1, 2023

ZimVie Announces First U.S. Surgery with the 4.5mm Mobi-C® Cervical Disc

GlobeNewswire October 31, 2023

ZimVie Announces Over 2,000 Children Have Received The Tether(TM) VBT

GlobeNewswire October 24, 2023

ZimVie Announces the Launch of Azure(TM) Multi-Platform Product Solutions

GlobeNewswire October 17, 2023

ZimVie to Report Third Quarter 2023 Financial Results on November 1, 2023

GlobeNewswire October 11, 2023

ZimVie Announces the Recent Launch of Biotivity(TM) A/C Plus Membrane

GlobeNewswire October 10, 2023

ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study

GlobeNewswire September 26, 2023

ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing

GlobeNewswire August 17, 2023

ZimVie Announces FDA Approval for New Mobi-C® Implant

GlobeNewswire August 10, 2023

ZimVie Reports Second Quarter 2023 Financial Results and Provides Update to Annual Guidance

GlobeNewswire August 2, 2023

ZimVie to Report Second Quarter 2023 Financial Results on August 2, 2023

GlobeNewswire July 12, 2023

ZimVie to Present at the Stifel 2023 Jaws & Paws Conference

GlobeNewswire May 22, 2023

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Announces Investigation into ZimVie Inc. (ZIMV)

Newsfile May 16, 2023